China Strategy and Implementation— Vision Care

Context: China Growth Strategy

• Scope: Medteryx was engaged to establish a self sustaining Research Institute in China for value-added vision care products
• Develop China entry strategy including well documented $multi-million business case
• Provide high level cash-flow budgets.  Including forecasting funds required to support breakeven within 4 years
• Review and short list potential JV partners
• Assess and secure approvals from Chinese authorities for legal company structures —WOFE and FICE

Results delivered

Client achieved breakeven position on China investments earlier than plan including:

• Strategic alliance with a major Ophthalmic Centre/Key Lab University
• JV commercialisation partnership with a major distributor of ophthalmic products/2000+ points of presence across China
• Dedicated research facility in Guangzhou
• Representative office in Beijing for SFDA
• Cash breakeven ahead of plan.